What You Should Know About Tenofovir Alafenamide Side Effects

If you've been prescribed Tenofovir Alafenamide (brand name Vemlidy), it's natural to wonder about side effects. Like all medications, Tenofovir Alafenamide can cause side effects in some people — but most are mild and manageable. Knowing what to expect can help you feel more prepared and recognize when something needs medical attention.

What Is Tenofovir Alafenamide?

Tenofovir Alafenamide is a nucleotide reverse transcriptase inhibitor (NtRTI) made by Gilead Sciences. It's FDA-approved to treat chronic hepatitis B virus (HBV) infection in adults and children ages 6 and older who weigh at least 25 kg with compensated liver disease. It works by blocking the virus's ability to copy itself inside your cells. For more details, see our guide on what Tenofovir Alafenamide is and how it's used.

Common Side Effects

The following side effects were reported in clinical trials. Most are mild and may improve as your body adjusts to the medication:

• Headache — reported in about 12% of patients
• Abdominal pain — about 9% of patients
• Cough — about 8% of patients
• Back pain — about 6% of patients
• Fatigue — about 6% of patients
• Nausea — about 6% of patients
• Joint pain (Arthralgia) — about 5% of patients
• Diarrhea — about 5% of patients
• Indigestion (Dyspepsia) — about 5% of patients

These side effects are generally not dangerous and often go away on their own within the first few weeks of treatment. If any of them become bothersome or don't improve, talk to your doctor.

Serious Side Effects

While uncommon, Tenofovir Alafenamide can cause serious side effects that require immediate medical attention:

Severe Hepatitis B Flare-Ups After Stopping

This is the most critical warning. Vemlidy carries a boxed warning (the FDA's strongest warning) about severe acute exacerbation of hepatitis B if you stop taking the medication. If you discontinue Tenofovir Alafenamide, your hepatitis B can come back much worse than before. Never stop taking this medication without your doctor's guidance. Your doctor will monitor your liver function closely for at least several months after discontinuation.

Kidney Problems

Tenofovir Alafenamide can cause new or worsening kidney impairment in some patients. Symptoms to watch for include:

• Decreased urination
• Swelling in your legs, ankles, or feet
• Unusual fatigue

Your doctor will check your kidney function with blood tests before and during treatment.

Lactic Acidosis

In rare cases, nucleotide analogs like Tenofovir Alafenamide can cause a buildup of lactic acid in the blood. Symptoms include:

• Unusual muscle pain
• Difficulty breathing
• Stomach pain with nausea and vomiting
• Cold or blue skin
• Dizziness or lightheadedness

Seek emergency medical help if you experience these symptoms.

Severe Liver Problems (Hepatomegaly with Steatosis)

Though rare, Tenofovir Alafenamide can cause an enlarged, fatty liver. This is a medical emergency. Watch for severe nausea, upper stomach pain, or unusual tiredness.

Elevated LDL Cholesterol

Some patients taking Tenofovir Alafenamide have experienced increased LDL ("bad") cholesterol levels. Your doctor may monitor your cholesterol during treatment and recommend dietary changes or medication if needed.

Side Effects in Specific Populations

Pregnant or Breastfeeding Women

Tenofovir Alafenamide is classified as Pregnancy Category B3 in Australia. A pregnancy exposure registry is available for monitoring outcomes. It is not known whether this medication passes into breast milk. Talk to your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Children

Vemlidy is approved for pediatric patients ages 6 and older weighing at least 25 kg. Side effects in children are generally similar to those seen in adults.

Patients with Kidney Issues

No dosage adjustment is needed for patients with a creatinine clearance of 15 mL/min or greater. However, Vemlidy is not recommended for patients with end-stage renal disease who are not on hemodialysis.

Patients with HIV Co-Infection

Patients should be tested for HIV-1 before starting Vemlidy. Tenofovir Alafenamide alone should not be used in patients co-infected with HIV-1, as this could lead to HIV-1 resistance. If you have both hepatitis B and HIV, your doctor will prescribe a combination regimen.

How to Manage Side Effects

Here are some practical tips for dealing with common Tenofovir Alafenamide side effects:

• Take it with food — Vemlidy should be taken with food, which can help reduce nausea and improve absorption.
• Stay hydrated — Drinking plenty of water can help with headaches and support kidney function.
• Track your symptoms — Keep a simple log of any side effects and when they occur so you can share it with your doctor.
• Don't skip doses or stop suddenly — Stopping Tenofovir Alafenamide abruptly can cause a dangerous hepatitis B flare. Always follow your doctor's instructions.
• Report new symptoms promptly — If you notice decreased urination, unusual muscle pain, difficulty breathing, or severe stomach pain, contact your doctor or go to the emergency room right away.

For information on medications that can interact with Tenofovir Alafenamide and potentially worsen side effects, read our guide on Tenofovir Alafenamide drug interactions.

Final Thoughts

Most people who take Tenofovir Alafenamide tolerate it well. Common side effects like headache, nausea, and fatigue are usually mild and temporary. The serious side effects — particularly the risk of hepatitis B flare-ups after stopping — are important to understand but rare when the medication is taken as directed under medical supervision.

If you have concerns about side effects, talk to your prescriber. They can help you weigh the benefits of treatment against the risks and make adjustments if needed. And if you need help finding Tenofovir Alafenamide at an affordable price, Medfinder can help you locate it in stock near you.